Article(id=1330233532728848673, tenantId=1146029695717560320, journalId=1319690259887390882, issueId=1330233532238115104, articleNumber=null, orderNo=null, doi=10.16522/j.cnki.cjph.2024.01.001, pmid=null, cstr=null, oa=null, hot=null, price=null, onlineType=0, articleFormat=0, articleType=null, articleTypeStr=null, receivedDate=1704038400000, receivedDateStr=2024-01-01, revisedDate=null, revisedDateStr=null, acceptedDate=null, acceptedDateStr=null, onlineDate=1795081988745, onlineDateStr=2026-11-19, pubDate=1704816000000, pubDateStr=2024-01-10, doiRegisterDate=null, doiRegisterDateStr=null, onlineIssueDate=1795081988745, onlineIssueDateStr=2026-11-19, onlineJustAcceptDate=null, onlineJustAcceptDateStr=null, onlineFirstDate=null, onlineFirstDateStr=null, sourceXml=null, magXml=null, createTime=1795081988745, creator=13701087609, updateTime=1795081988745, updator=13701087609, issue=Issue{id=1330233532238115104, tenantId=1146029695717560320, journalId=1319690259887390882, year='2024', volume='55', issue='1', pageStart='1', pageEnd='164', issueExtLink='null', onlineDate='null', pubDate='1704816000000', pubDateStr='2024-01-10', beforeIssueId=null, nextIssueId=null, price=null, status=1, issueComplete=1, articleOrder=1, issueType=-1, specialIssue=null, createTime=1795081988628, creator='13701087609', updateTime=1795082672017, updator='13701087609', preIssue=null, nextIssue=null, articleTotal=null, ext={EN=IssueExt(id=1330236399149756518, tenantId=1146029695717560320, journalId=1319690259887390882, issueId=1330233532238115104, language=EN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=), CN=IssueExt(id=1330236399149756519, tenantId=1146029695717560320, journalId=1319690259887390882, issueId=1330233532238115104, language=CN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=)}, issueFiles=null, downloadFileDto=null}, startPage=1, endPage=27, ext={EN=ArticleExt(id=1330233532946952482, articleId=1330233532728848673, tenantId=1146029695717560320, journalId=1319690259887390882, language=EN, title=Overviews of the New Drugs in 2023 Approved by U.S. FDA, columnId=1327671169563603616, journalTitle=Chinese Journal of Pharmaceuticals, columnName=Perspectives, runingTitle=null, highlight=null, articleAbstract=

The U.S. FDA approved 53 new drugs in 2023, including 31 chemical small molecules, 21 biological products and 1 botanical drug. According to the prescription information for professionals and the related literature as well as patent information, this review describes the descriptions, indications, mechanism of action, dosage forms and strengths, adverse reactions, and one synthetic route of the chemical small molecules, and brief information about biological and botanical products.

, authors=Wei ZHOU, Kuaile LIN, Weicheng ZHOU*, authorsList=Wei ZHOU, Kuaile LIN, Weicheng ZHOU, authorCompany=null, correspAuthors=Weicheng ZHOU, authorNote=null, correspAuthorsNote=null, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=null, magXml=null, pdfUrl=null, pdf=null, pdfFileSize=null, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=null, mapNumber=null, fund=null), CN=ArticleExt(id=1330233533450268965, articleId=1330233532728848673, tenantId=1146029695717560320, journalId=1319690259887390882, language=CN, title=2023年美国FDA批准上市的新药简介, columnId=1327671169823650466, journalTitle=中国医药工业杂志, columnName=专论, runingTitle=null, highlight=null, articleAbstract=

2023年美国FDA批准上市新药53个,其中化学小分子药物31个,生物制品21个,植物药1个。文章根据FDA批准的新药说明书及相关文献和专利情况,简要介绍这些药物的概况、适应证、作用机制、剂型规格、不良反应等,以及化学小分子药物的合成路线。

, authors=周薇, 林快乐, 周伟澄*, authorsList=周薇, 林快乐, 周伟澄, authorCompany=null, correspAuthors=周伟澄, authorNote=

周伟澄,博士,荣获“第四届中国青年科技奖”“国家级有突出贡献的中青年科技专家”“上海市优秀学科带头人”和“上海市领军人才”等称号;享受国务院特殊津贴;上海医药工业研究院研究员,博士生导师,《中国医药工业杂志》总编辑;上海交通大学药学院兼职教授,复旦大学药学院博士生导师。研究课题多次受到联合国开发计划署/世界银行/世界卫生组织、国家科技攻关项目、国家重大新药创制、国家973项目等的资助。获国家一类新药证书1份,其他类别新药证书5份。国家授权专利60多项。主编《高等药物化学选论》《化学药物制备的工业化技术》两本研究生教科书,由化学工业出版社出版。发表论文190多篇,培养博士研究生27人,硕士研究生39人。

周薇(1998—),女,硕士研究生,专业方向:药物化学。

, correspAuthorsNote=
周伟澄(1958—),男,研究员,博士生导师,从事药物化学研究。E-mail:
, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=dRE+njwYDxVe8XM0ShKMBA==, magXml=vMv9dxQEP7P5l+19ptK21Q==, pdfUrl=null, pdf=Yt2LxK4gaM21EOucpiiUqg==, pdfFileSize=4591555, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=aBNxfB9iYsfH9ppUEZ+j8g==, mapNumber=null, fund=null)}, authors=[Author(id=1330233533794201898, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233532728848673, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1330233533861310764, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233532728848673, authorId=1330233533794201898, language=EN, stringName=Wei ZHOU, firstName=Wei, middleName=null, lastName=ZHOU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Shanghai Institute of Pharmaceutical Industry, China State Institute of Pharmaceutical Industry, Shanghai 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330233533941002541, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233532728848673, authorId=1330233533794201898, language=CN, stringName=周薇, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=中国医药工业研究总院上海医药工业研究院,上海 201203, bio={"content":"

周薇(1998—),女,硕士研究生,专业方向:药物化学。

"}, bioImg=null, bioContent=

周薇(1998—),女,硕士研究生,专业方向:药物化学。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330233533714510118, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233532728848673, xref=null, ext=[AuthorCompanyExt(id=1330233533722898727, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233532728848673, companyId=1330233533714510118, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Shanghai Institute of Pharmaceutical Industry, China State Institute of Pharmaceutical Industry, Shanghai 201203), AuthorCompanyExt(id=1330233533731287336, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233532728848673, companyId=1330233533714510118, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=中国医药工业研究总院上海医药工业研究院,上海 201203)])]), Author(id=1330233534024888623, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233532728848673, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1330233534112969009, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233532728848673, authorId=1330233534024888623, language=EN, stringName=Kuaile LIN, firstName=Kuaile, middleName=null, lastName=LIN, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Shanghai Institute of Pharmaceutical Industry, China State Institute of Pharmaceutical Industry, Shanghai 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330233534196855090, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233532728848673, authorId=1330233534024888623, language=CN, stringName=林快乐, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=中国医药工业研究总院上海医药工业研究院,上海 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330233533714510118, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233532728848673, xref=null, ext=[AuthorCompanyExt(id=1330233533722898727, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233532728848673, companyId=1330233533714510118, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Shanghai Institute of Pharmaceutical Industry, China State Institute of Pharmaceutical Industry, Shanghai 201203), AuthorCompanyExt(id=1330233533731287336, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233532728848673, companyId=1330233533714510118, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=中国医药工业研究总院上海医药工业研究院,上海 201203)])]), Author(id=1330233534305906996, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233532728848673, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=zhouweicheng58@163.com, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1330233534368821558, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233532728848673, authorId=1330233534305906996, language=EN, stringName=Weicheng ZHOU, firstName=Weicheng, middleName=null, lastName=ZHOU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=*, address=Shanghai Institute of Pharmaceutical Industry, China State Institute of Pharmaceutical Industry, Shanghai 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330233534431736119, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233532728848673, authorId=1330233534305906996, language=CN, stringName=周伟澄, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=*, address=中国医药工业研究总院上海医药工业研究院,上海 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330233533714510118, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233532728848673, xref=null, ext=[AuthorCompanyExt(id=1330233533722898727, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233532728848673, companyId=1330233533714510118, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Shanghai Institute of Pharmaceutical Industry, China State Institute of Pharmaceutical Industry, Shanghai 201203), AuthorCompanyExt(id=1330233533731287336, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233532728848673, companyId=1330233533714510118, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=中国医药工业研究总院上海医药工业研究院,上海 201203)])])], keywords=[Keyword(id=1330233534528205112, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233532728848673, language=EN, orderNo=1, keyword=FDA), Keyword(id=1330233534591119673, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233532728848673, language=EN, orderNo=2, keyword=new drug approval), Keyword(id=1330233534649839930, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233532728848673, language=EN, orderNo=3, keyword=indication), Keyword(id=1330233534708560187, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233532728848673, language=EN, orderNo=4, keyword=mechanism of action), Keyword(id=1330233534767280444, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233532728848673, language=EN, orderNo=5, keyword=synthetic route), Keyword(id=1330233534830195005, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233532728848673, language=CN, orderNo=1, keyword=FDA), Keyword(id=1330233534897303870, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233532728848673, language=CN, orderNo=2, keyword=新药批准), Keyword(id=1330233534972801343, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233532728848673, language=CN, orderNo=3, keyword=适应证), Keyword(id=1330233536579219776, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233532728848673, language=CN, orderNo=4, keyword=作用机制), Keyword(id=1330233536642134337, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233532728848673, language=CN, orderNo=5, keyword=合成路线)], refs=[Reference(id=1330233536755380546, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233532728848673, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[1], rfOrder=0, authorNames=null, journalName=null, refType=null, unstructuredReference=毕思举,林快乐,刘玲玲,等.2022年美国FDA批准上市的新药简介[J].中国医药工业杂志,2023,54(1):1-18., articleTitle=null, refAbstract=null), Reference(id=1330233536809906499, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233532728848673, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[2], rfOrder=1, authorNames=null, journalName=null, refType=null, unstructuredReference=FDA.Novel Drug Approvals for 2023 [EB/OL].[2024-01-01].https://www.fda.gov/drugs/new-drugs-fda-cders-new-molecular-entities-and-new-therapeutic-biological-products/novel-drug-approvals-2023., articleTitle=null, refAbstract=null), Reference(id=1330233536885403972, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233532728848673, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[3], rfOrder=2, authorNames=null, journalName=null, refType=null, unstructuredReference=GUISOT N.Compounds useful as kinase inhibitors: WO, 2017103611A1 [P].2017-06-22., articleTitle=null, refAbstract=null), Reference(id=1330233536952512837, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233532728848673, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[4], rfOrder=3, authorNames=null, journalName=null, refType=null, unstructuredReference=MARKEY M.Processes and compounds: WO, 2020167855A1 [P].2020-08-20., articleTitle=null, refAbstract=null), Reference(id=1330233537011233094, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233532728848673, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[5], rfOrder=4, authorNames=null, journalName=null, refType=null, unstructuredReference=BHAGWAT S.Imidazolothiazole compounds for the treatment of disease: WO, 2007109120A2 [P].2007-09-27., articleTitle=null, refAbstract=null), Reference(id=1330233537065759047, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233532728848673, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[6], rfOrder=5, authorNames=null, journalName=null, refType=null, unstructuredReference=SU W G, ZHANG W H, YAN X Q, et al.Quinazoline derivatives: WO, 2009137797A2 [P].2009-11-12., articleTitle=null, refAbstract=null), Reference(id=1330233537141256520, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233532728848673, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[7], rfOrder=6, authorNames=null, journalName=null, refType=null, unstructuredReference=CUI J J, LI Y S, ROGERS E W, et al.Diaryl macrocycles as modulators of protein kinases: WO, 2015112806A2 [P].2015-07-30., articleTitle=null, refAbstract=null), Reference(id=1330233537225142601, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233532728848673, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[8], rfOrder=7, authorNames=null, journalName=null, refType=null, unstructuredReference=JOHNSON P D, LEACH A, LUKE R W A, et al.Pyrrolo[2,3-d]pyrimidin derivatives as protein kinase B inhibitors: WO, 2009047563A1 [P].2009-04-16., articleTitle=null, refAbstract=null), Reference(id=1330233537292251466, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233532728848673, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[9], rfOrder=8, authorNames=null, journalName=null, refType=null, unstructuredReference=BORDNEY M A, AUPERIN D D, BECKER S L, et al.Design, synthesis, and in vivo characterization of a novel series of tetralin amino imidazoles as γ-secretase inhibitors: discovery of PF-3084014 [J].Bioorg Med Chem Lett, 2011, 21(9): 2637-2640., articleTitle=null, refAbstract=null), Reference(id=1330233537380331851, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233532728848673, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[10], rfOrder=9, authorNames=null, journalName=null, refType=null, unstructuredReference=CANN R O, CHEN C H, GAO Q, et al.Selection of an enantioselective process for the preparation of a CGRP receptor inhibitor [J].Org Process Res Dev, 2012, 16(12): 1953-1966., articleTitle=null, refAbstract=null), Reference(id=1330233537514549580, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233532728848673, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[11], rfOrder=10, authorNames=null, journalName=null, refType=null, unstructuredReference=CHATURVEDULA P V, MERCER S E, PIN S S, et al.Discovery of (R)-N-(3-(7-methyl-1H-indazol-5-yl)-1-(4-(1-methylpiperidin-4-yl)-1-oxopropan-2-yl)-4-(2-oxo-1,2-dihydroquinolin-3-yl)-piperidine-1-carboxamide(BMS-742413): a potent human CGRP antagonist with superior safety profile for the treatment of migraine through intranasal delivery [J].Bioorg Med Chem Lett, 2013, 23(11): 3157-3161., articleTitle=null, refAbstract=null), Reference(id=1330233537627795789, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233532728848673, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[12], rfOrder=11, authorNames=null, journalName=null, refType=null, unstructuredReference=HARRIS P W R, BRIMBLE M A, MUIR V J, et al.Synthesis of proline-modified analogues of the neuroprotective agent glycyl-L-prolyl-glutamic acid(GPE)[J].Tetrahedron, 2005, 61(42): 10018-10035., articleTitle=null, refAbstract=null), Reference(id=1330233537736847694, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233532728848673, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[13], rfOrder=12, authorNames=null, journalName=null, refType=null, unstructuredReference=BOTELLA G M, HARRISON B L, ROBICHAUD A J, et al.19-Nor C3,3-disubstituted C21-N-pyrazolyl steroids and methods of use thereof: WO, 2014169833A1 [P].2014-10-23., articleTitle=null, refAbstract=null), Reference(id=1330233537799762255, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233532728848673, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[14], rfOrder=13, authorNames=null, journalName=null, refType=null, unstructuredReference=TEMPLE D L.2-[4-([4,4-Dialkyl-2,6-piperidinedion-1-yl]-butyl)-1-piperazinyl]pyrimidines verfahren zu herstellung und pharmazeutische mittel, die dieseverbindungen enthalten: DE, 3248160A1 [P].1983-07-07., articleTitle=null, refAbstract=null), Reference(id=1330233537875259728, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233532728848673, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[15], rfOrder=14, authorNames=null, journalName=null, refType=null, unstructuredReference=XU B H, FENG Y, CHENG H W, et al.C-Aryl glucosides substituted at the 4'-position as potent and selective renal sodium-dependent glucose co-transporter 2(SGLT2)inhibitors for the treatment of type 2 diabetes [J].Bioora Med Chem Lett, 2011, 21(15): 4465-4470., articleTitle=null, refAbstract=null), Reference(id=1330233537967534417, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233532728848673, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[16], rfOrder=15, authorNames=null, journalName=null, refType=null, unstructuredReference=XU G, XU B H, SONG Y L, et al.An efficient method for synthesis of bexagliflozin and its carbon-13 labeled analogue[J].Tetrahedron Lett, 2016, 57(42): 4684-4687., articleTitle=null, refAbstract=null), Reference(id=1330233538026254674, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233532728848673, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[17], rfOrder=16, authorNames=null, journalName=null, refType=null, unstructuredReference=GOODWIN N C, HARRISON B A, KIMBALL S D, et al.Inhibitor of sodium glucose co-transpoter 2 and methods of their use: US, 20080221164A1 [P].2008-09-11., articleTitle=null, refAbstract=null), Reference(id=1330233538080780627, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233532728848673, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[18], rfOrder=17, authorNames=null, journalName=null, refType=null, unstructuredReference=DUFFY K J, FITCH D M, JIN J, et al.Polyl hydroxylase inhibitors: WO, 2007150011A2 [P].2007-12-27., articleTitle=null, refAbstract=null), Reference(id=1330233538143695188, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233532728848673, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[19], rfOrder=18, authorNames=null, journalName=null, refType=null, unstructuredReference=MURUGESAN N, GU Z X, FADNIS L, et al.Dual angiotensin II and endothelin a receptor antagonists: synthesis of 2′-substituted N-3-isoxazolyl biphenylsulfonamides with improved potency and pharmacokinetics [J].J Med Chem, 2005, 48(1): 171-179., articleTitle=null, refAbstract=null), Reference(id=1330233538202415445, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233532728848673, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[20], rfOrder=19, authorNames=null, journalName=null, refType=null, unstructuredReference=ERIC A, ANDREA D, LIU X F.2,2-Difluoropropionamide derivatives of bardoxolone methyl, polymorphic forms and methods of use thereof: WO, 2013163344A1 [P].2013-10-31., articleTitle=null, refAbstract=null), Reference(id=1330233538282107222, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233532728848673, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[21], rfOrder=20, authorNames=null, journalName=null, refType=null, unstructuredReference=HUANG J, ZHU L J, JIANG W, et al.Echinocandin analogues and preparation method therefor: WO, 2021110125 A1 [P].2021-06-10., articleTitle=null, refAbstract=null), Reference(id=1330233538361798999, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233532728848673, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[22], rfOrder=21, authorNames=null, journalName=null, refType=null, unstructuredReference=GRAHAM C N, PAULO F G D S P, NADEGE G, et al.Tetrahydro-pyrido-pyrimidine derivatives: WO, 2012004299A1 [P].2012-01-12., articleTitle=null, refAbstract=null), Reference(id=1330233538424713560, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233532728848673, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[23], rfOrder=22, authorNames=null, journalName=null, refType=null, unstructuredReference=HAMID H, GUILLAUME D, GRAEME F.Novel N-acyl-(3-substituted)-(8-substituted)-5,6-dihydro-[1,2,4]-triazolo[4,3-a]pyrazines as selective NK-3 receptor antagonists, pharmaceutical composition, methods for use in NK-3 receptor-mediated disorders: WO, 2014154895A1[P].2014-10-02., articleTitle=null, refAbstract=null), Reference(id=1330233538483433817, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233532728848673, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[24], rfOrder=23, authorNames=null, journalName=null, refType=null, unstructuredReference=IVANOV B P, LÖSCHER F, NICOLETTI S.Process for the preparation of semiflurorinated alkanes using grignard reagents: US, 20200339492A1 [P].2020-10-29., articleTitle=null, refAbstract=null), Reference(id=1330233538550542682, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233532728848673, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[25], rfOrder=24, authorNames=null, journalName=null, refType=null, unstructuredReference=RHYS O D, YOUNGJIN P M, RICHARDR M, et al.Nitrile-containing antiviral compounds: WO, 2021250648A1[P].2021-12-16., articleTitle=null, refAbstract=null), Reference(id=1330233538613457243, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233532728848673, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[26], rfOrder=25, authorNames=null, journalName=null, refType=null, unstructuredReference=FRANK B M, CASIMIRO-GARCIA A, CHE Y, et al.Pyrrolo[2,3-d]pyrimidinyl, pyrrolo[2,3-b]pyrazinyl and pyrrolo[2,3-d]pyridinyl acrylamides: WO, 2015083028A1[P].2015-06-11., articleTitle=null, refAbstract=null), Reference(id=1330233538667983196, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233532728848673, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[27], rfOrder=26, authorNames=null, journalName=null, refType=null, unstructuredReference=MARIE D J, GUANMIN W, JINGDAN H, et al.Process for making an isoxazoline compound and intermediate thereof: WO, 2022020585A1 [P].2022-01-27., articleTitle=null, refAbstract=null), Reference(id=1330233538743480669, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233532728848673, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[28], rfOrder=27, authorNames=null, journalName=null, refType=null, unstructuredReference=JEAN-MARC L, MARK R D, BRIAN S E.Retinoids for the treatment of emphysema: WO, 0228810A2 [P].2002-04-11., articleTitle=null, refAbstract=null), Reference(id=1330233538806395230, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233532728848673, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[29], rfOrder=28, authorNames=null, journalName=null, refType=null, unstructuredReference=JOHN B C, CRAIG D A, THOMAS F J, et al.Phenyl amino pyrimidine compounds and uses thereof: WO, 2008109943A1 [P].2008-09-18., articleTitle=null, refAbstract=null), Reference(id=1330233538873504095, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233532728848673, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[30], rfOrder=29, authorNames=null, journalName=null, refType=null, unstructuredReference=ROBERT M J, JUERG L, SANGDON H, et al.Substituted 1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl) acetic acid derivatives useful in the treatment of autoimmune and inflammatory disorders: WO, 2010011316A1 [P].2010-01-28., articleTitle=null, refAbstract=null), Reference(id=1330233538940612960, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233532728848673, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[31], rfOrder=30, authorNames=null, journalName=null, refType=null, unstructuredReference=EUGENE P O, RICHARD C R.Diuretic 1,4,9(11)-pregnatrienes: US, 3284477 [P].1966-11-08., articleTitle=null, refAbstract=null), Reference(id=1330233539016110433, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233532728848673, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[32], rfOrder=31, authorNames=null, journalName=null, refType=null, unstructuredReference=NOVARTIS A G, CHRISTOPHER A, MICHAEL P C, et al.Piperidinyl indole derivatives and their use as complement factor B inhibitors: WO, 2015009616A1 [P].2015-01-22., articleTitle=null, refAbstract=null)], funds=null, companyList=[AuthorCompany(id=1330233533714510118, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233532728848673, xref=null, ext=[AuthorCompanyExt(id=1330233533722898727, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233532728848673, companyId=1330233533714510118, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Shanghai Institute of Pharmaceutical Industry, China State Institute of Pharmaceutical Industry, Shanghai 201203), AuthorCompanyExt(id=1330233533731287336, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233532728848673, companyId=1330233533714510118, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=中国医药工业研究总院上海医药工业研究院,上海 201203)])], figs=null, attaches=null, journal=Journal(id=1319689822849302687, delFlag=0, nameCn=中国医药工业杂志, nameEn=Chinese Journal of Pharmaceuticals, nameHistory1=null, nameHistory2=null, issn=1001-8255, eissn=null, cn=31-1243/R, coden=ZYGZEA, periodic=0, language=CN, oaType=null, ccby=null, superviseOffice=null, ownerOffice=null, pubOffice=null, editorOffice=null, officeType=null, aims=null, clcCode=null, officeProv=null, officeCity=null, officeAddr=null, officeZip=null, officeEmail=null, officePhone=null, editDirector=null, officeDirector=null, officeDirectorPhone=null, officeStaffNum=null, officeEmpNum=null, coverPicUrl=etiWDuwx2KO274LHw88KJA==, journalPrice=null, startedYear=null, abbrevIsoEn=Chinese Journal of Pharmaceuticals, journalRemark=null, publicationField=null, createdTime=1792568172420, updatedTime=1792747450744, createdBy=18614031015, updatedBy=13701087609, firstLetterCn=Z, firstLetterEn=Z, subjectCode=Medical and Pharmaceutical Sciences, subjectName=null, subjectCodeEn=Medical and Pharmaceutical Sciences, subjectNameEn=null, picCn=etiWDuwx2KO274LHw88KJA==, picEn=ip9NF4dK57AmNrCiZ6hmdw==, jcr=null, cjcr=null, exts=[JournalExt(id=1320441770761105589, language=CN, name=中国医药工业杂志, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747450771, updatedTime=1792747450771, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=https://zgyygyauthor.cast.org.cn/webm, submissionEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionReviewUrl=https://zgyygyauthor.cast.org.cn/webm, submissionCeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionAeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, option={"copyright":""}), JournalExt(id=1320441770819825846, language=EN, name=Chinese Journal of Pharmaceuticals, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747450785, updatedTime=1792747450785, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=https://zgyygyauthor.cast.org.cn/webm, submissionEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionReviewUrl=https://zgyygyauthor.cast.org.cn/webm, submissionCeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionAeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, option={"copyright":""})], databaseList=null, tenantJournalId=1319690259887390882, websiteList=[Website(id=1319720771623174732, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690259887390882, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/zgyygy/CN, language=CN, createTime=1792575551181, createBy=18614031015, updateTime=1792746040843, updateBy=18614031015, name=中国医药工业杂志-中文, tplId=1146099689490845704, title=中国医药工业杂志, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428487504769041, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=articleTextType, value=kx, createTime=1792982702375, updateTime=1792982702375, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487475408910, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=banner, value=https://castjournals.cast.org.cn/joweb/zgyygy/CN/file/pic?fileId=i/3+mr8MqWvs6ArWn9VK7w==, createTime=1792982702368, updateTime=1792982702368, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487538323476, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=grayFlag, value=0, createTime=1792982702383, updateTime=1792982702383, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487462825997, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=logo, value=https://castjournals.cast.org.cn/joweb/zgyygy/CN/file/pic?fileId=7mfvc3zMp/tsQUIOlJrNFQ==, createTime=1792982702365, updateTime=1792982702365, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487571877910, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=minRunFlag, value=0, createTime=1792982702391, updateTime=1792982702391, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487496380432, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/zgyygy/CN/file/pic, createTime=1792982702373, updateTime=1792982702373, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487563489301, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=silenceFlag, value=0, createTime=1792982702389, updateTime=1792982702389, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487483797519, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_cn_619/, createTime=1792982702370, updateTime=1792982702370, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487517351954, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=themeColor, value=null, createTime=1792982702378, updateTime=1792982702378, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487525740563, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982702380, updateTime=1792982702380, creator=18614031015, updator=18614031015)]), Website(id=1319720771702866512, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690259887390882, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/zgyygy/EN, language=EN, createTime=1792575551200, createBy=18614031015, updateTime=1792746037543, updateBy=18614031015, name=中国医药工业杂志-英文, tplId=1146101810881728533, title=Chinese Journal of Pharmaceuticals, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428509638111261, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=articleTextType, value=kx, createTime=1792982707652, updateTime=1792982707652, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509579391002, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=banner, value=https://castjournals.cast.org.cn/joweb/zgyygy/EN/file/pic?fileId=i/3+mr8MqWvs6ArWn9VK7w==, createTime=1792982707638, updateTime=1792982707638, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509680054304, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=grayFlag, value=0, createTime=1792982707662, updateTime=1792982707662, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509566808089, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=logo, value=https://castjournals.cast.org.cn/joweb/zgyygy/EN/file/pic?fileId=7mfvc3zMp/tsQUIOlJrNFQ==, createTime=1792982707635, updateTime=1792982707635, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509701025826, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=minRunFlag, value=0, createTime=1792982707667, updateTime=1792982707667, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509629722652, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/zgyygy/EN/file/pic, createTime=1792982707650, updateTime=1792982707650, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509688442913, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=silenceFlag, value=0, createTime=1792982707664, updateTime=1792982707664, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509587779611, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_en_623/, createTime=1792982707640, updateTime=1792982707640, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509663277086, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=themeColor, value=null, createTime=1792982707658, updateTime=1792982707658, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509671665695, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982707660, updateTime=1792982707660, creator=18614031015, updator=18614031015)])], journalTitle=中国医药工业杂志, weixinUrl=null, journalUrl=http://www.cjph.com.cn/, iacademicId=null, status=1, seqNo=null, journalTitleEn=Chinese Journal of Pharmaceuticals, journalPhotoCn=etiWDuwx2KO274LHw88KJA==, journalPhotoEn=ip9NF4dK57AmNrCiZ6hmdw==, journalFirstLetter=Z, journalRecommend=null, journalNew=null, journalCollection=null, jcrJf=null, cjcrJf=null, jcrJfStr=null, cjcrJfStr=null, submissionFirstDecision=null, sciSubjectClassification=null, casSubjectClassification=null, citeScore=null, totalCitationFrequency=null, icpCode=null, psCode=null, advertisingLicenseCode=null, copyrightInformation=null, country=null, option=, provinceCode=null, provinceName=null, collectFlag=false, interPubPlatform=, interPubPlatformUrl=null), detailUrlCn=https://castjournals.cast.org.cn/joweb/zgyygy/CN/10.16522/j.cnki.cjph.2024.01.001, detailUrlEn=https://castjournals.cast.org.cn/joweb/zgyygy/EN/10.16522/j.cnki.cjph.2024.01.001, pdfUrlCn=https://castjournals.cast.org.cn/joweb/zgyygy/CN/PDF/10.16522/j.cnki.cjph.2024.01.001, pdfUrlEn=https://castjournals.cast.org.cn/joweb/zgyygy/EN/PDF/10.16522/j.cnki.cjph.2024.01.001, aliStartDate=0, aliEndDate=0, collectionFlag=false, citedCount=null, citedUrl=null, previewStatus=0, delFlag=0, hasFullText=0, orderTime=1704816000000, fullTextJson=null, articleText=null, reference=null)
收藏切换
2023年美国FDA批准上市的新药简介
周薇 , 林快乐 , 周伟澄 *
中国医药工业杂志 | 专论 2024,55(1): 1-27
收起
收藏切换
中国医药工业杂志 |专论 2024 , 55 (1) : 1 -27
2023年美国FDA批准上市的新药简介
全屏
[Author(id=1330233533794201898, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233532728848673, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1330233533861310764, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233532728848673, authorId=1330233533794201898, language=EN, stringName=Wei ZHOU, firstName=Wei, middleName=null, lastName=ZHOU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Shanghai Institute of Pharmaceutical Industry, China State Institute of Pharmaceutical Industry, Shanghai 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330233533941002541, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233532728848673, authorId=1330233533794201898, language=CN, stringName=周薇, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=中国医药工业研究总院上海医药工业研究院,上海 201203, bio={"content":"

周薇(1998—),女,硕士研究生,专业方向:药物化学。

"}, bioImg=null, bioContent=

周薇(1998—),女,硕士研究生,专业方向:药物化学。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330233533714510118, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233532728848673, xref=null, ext=[AuthorCompanyExt(id=1330233533722898727, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233532728848673, companyId=1330233533714510118, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Shanghai Institute of Pharmaceutical Industry, China State Institute of Pharmaceutical Industry, Shanghai 201203), AuthorCompanyExt(id=1330233533731287336, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233532728848673, companyId=1330233533714510118, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=中国医药工业研究总院上海医药工业研究院,上海 201203)])]), Author(id=1330233534024888623, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233532728848673, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1330233534112969009, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233532728848673, authorId=1330233534024888623, language=EN, stringName=Kuaile LIN, firstName=Kuaile, middleName=null, lastName=LIN, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Shanghai Institute of Pharmaceutical Industry, China State Institute of Pharmaceutical Industry, Shanghai 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330233534196855090, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233532728848673, authorId=1330233534024888623, language=CN, stringName=林快乐, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=中国医药工业研究总院上海医药工业研究院,上海 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330233533714510118, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233532728848673, xref=null, ext=[AuthorCompanyExt(id=1330233533722898727, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233532728848673, companyId=1330233533714510118, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Shanghai Institute of Pharmaceutical Industry, China State Institute of Pharmaceutical Industry, Shanghai 201203), AuthorCompanyExt(id=1330233533731287336, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233532728848673, companyId=1330233533714510118, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=中国医药工业研究总院上海医药工业研究院,上海 201203)])]), Author(id=1330233534305906996, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233532728848673, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=zhouweicheng58@163.com, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1330233534368821558, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233532728848673, authorId=1330233534305906996, language=EN, stringName=Weicheng ZHOU, firstName=Weicheng, middleName=null, lastName=ZHOU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=*, address=Shanghai Institute of Pharmaceutical Industry, China State Institute of Pharmaceutical Industry, Shanghai 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330233534431736119, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233532728848673, authorId=1330233534305906996, language=CN, stringName=周伟澄, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=*, address=中国医药工业研究总院上海医药工业研究院,上海 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330233533714510118, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233532728848673, xref=null, ext=[AuthorCompanyExt(id=1330233533722898727, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233532728848673, companyId=1330233533714510118, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Shanghai Institute of Pharmaceutical Industry, China State Institute of Pharmaceutical Industry, Shanghai 201203), AuthorCompanyExt(id=1330233533731287336, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233532728848673, companyId=1330233533714510118, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=中国医药工业研究总院上海医药工业研究院,上海 201203)])])]
周薇, 林快乐, 周伟澄*
作者信息
  • 中国医药工业研究总院上海医药工业研究院,上海 201203
通讯作者:
周伟澄(1958—),男,研究员,博士生导师,从事药物化学研究。E-mail:
作者简介:

周伟澄,博士,荣获“第四届中国青年科技奖”“国家级有突出贡献的中青年科技专家”“上海市优秀学科带头人”和“上海市领军人才”等称号;享受国务院特殊津贴;上海医药工业研究院研究员,博士生导师,《中国医药工业杂志》总编辑;上海交通大学药学院兼职教授,复旦大学药学院博士生导师。研究课题多次受到联合国开发计划署/世界银行/世界卫生组织、国家科技攻关项目、国家重大新药创制、国家973项目等的资助。获国家一类新药证书1份,其他类别新药证书5份。国家授权专利60多项。主编《高等药物化学选论》《化学药物制备的工业化技术》两本研究生教科书,由化学工业出版社出版。发表论文190多篇,培养博士研究生27人,硕士研究生39人。

周薇(1998—),女,硕士研究生,专业方向:药物化学。

Overviews of the New Drugs in 2023 Approved by U.S. FDA
Wei ZHOU, Kuaile LIN, Weicheng ZHOU*
Affiliations
  • Shanghai Institute of Pharmaceutical Industry, China State Institute of Pharmaceutical Industry, Shanghai 201203
出版时间: 2024-01-10 doi: 10.16522/j.cnki.cjph.2024.01.001
文章导航
收藏切换

2023年美国FDA批准上市新药53个,其中化学小分子药物31个,生物制品21个,植物药1个。文章根据FDA批准的新药说明书及相关文献和专利情况,简要介绍这些药物的概况、适应证、作用机制、剂型规格、不良反应等,以及化学小分子药物的合成路线。

FDA  /  新药批准  /  适应证  /  作用机制  /  合成路线

The U.S. FDA approved 53 new drugs in 2023, including 31 chemical small molecules, 21 biological products and 1 botanical drug. According to the prescription information for professionals and the related literature as well as patent information, this review describes the descriptions, indications, mechanism of action, dosage forms and strengths, adverse reactions, and one synthetic route of the chemical small molecules, and brief information about biological and botanical products.

FDA  /  new drug approval  /  indication  /  mechanism of action  /  synthetic route
周薇, 林快乐, 周伟澄. 2023年美国FDA批准上市的新药简介. 中国医药工业杂志, 2024 , 55 (1) : 1 -27 . DOI: 10.16522/j.cnki.cjph.2024.01.001
Wei ZHOU, Kuaile LIN, Weicheng ZHOU. Overviews of the New Drugs in 2023 Approved by U.S. FDA[J]. Chinese Journal of Pharmaceuticals, 2024 , 55 (1) : 1 -27 . DOI: 10.16522/j.cnki.cjph.2024.01.001

参考文献 引证文献
排序方式:
[1]
毕思举,林快乐,刘玲玲,等.2022年美国FDA批准上市的新药简介[J].中国医药工业杂志,2023,54(1):1-18.
[3]
GUISOT N.Compounds useful as kinase inhibitors: WO, 2017103611A1 [P].2017-06-22.
[4]
MARKEY M.Processes and compounds: WO, 2020167855A1 [P].2020-08-20.
[5]
BHAGWAT S.Imidazolothiazole compounds for the treatment of disease: WO, 2007109120A2 [P].2007-09-27.
[6]
SU W G, ZHANG W H, YAN X Q, et al.Quinazoline derivatives: WO, 2009137797A2 [P].2009-11-12.
[7]
CUI J J, LI Y S, ROGERS E W, et al.Diaryl macrocycles as modulators of protein kinases: WO, 2015112806A2 [P].2015-07-30.
[8]
JOHNSON P D, LEACH A, LUKE R W A, et al.Pyrrolo[2,3-d]pyrimidin derivatives as protein kinase B inhibitors: WO, 2009047563A1 [P].2009-04-16.
[9]
BORDNEY M A, AUPERIN D D, BECKER S L, et al.Design, synthesis, and in vivo characterization of a novel series of tetralin amino imidazoles as γ-secretase inhibitors: discovery of PF-3084014 [J].Bioorg Med Chem Lett, 2011, 21(9): 2637-2640.
[10]
CANN R O, CHEN C H, GAO Q, et al.Selection of an enantioselective process for the preparation of a CGRP receptor inhibitor [J].Org Process Res Dev, 2012, 16(12): 1953-1966.
[11]
CHATURVEDULA P V, MERCER S E, PIN S S, et al.Discovery of (R)-N-(3-(7-methyl-1H-indazol-5-yl)-1-(4-(1-methylpiperidin-4-yl)-1-oxopropan-2-yl)-4-(2-oxo-1,2-dihydroquinolin-3-yl)-piperidine-1-carboxamide(BMS-742413): a potent human CGRP antagonist with superior safety profile for the treatment of migraine through intranasal delivery [J].Bioorg Med Chem Lett, 2013, 23(11): 3157-3161.
[12]
HARRIS P W R, BRIMBLE M A, MUIR V J, et al.Synthesis of proline-modified analogues of the neuroprotective agent glycyl-L-prolyl-glutamic acid(GPE)[J].Tetrahedron, 2005, 61(42): 10018-10035.
[13]
BOTELLA G M, HARRISON B L, ROBICHAUD A J, et al.19-Nor C3,3-disubstituted C21-N-pyrazolyl steroids and methods of use thereof: WO, 2014169833A1 [P].2014-10-23.
[14]
TEMPLE D L.2-[4-([4,4-Dialkyl-2,6-piperidinedion-1-yl]-butyl)-1-piperazinyl]pyrimidines verfahren zu herstellung und pharmazeutische mittel, die dieseverbindungen enthalten: DE, 3248160A1 [P].1983-07-07.
[15]
XU B H, FENG Y, CHENG H W, et al.C-Aryl glucosides substituted at the 4'-position as potent and selective renal sodium-dependent glucose co-transporter 2(SGLT2)inhibitors for the treatment of type 2 diabetes [J].Bioora Med Chem Lett, 2011, 21(15): 4465-4470.
[16]
XU G, XU B H, SONG Y L, et al.An efficient method for synthesis of bexagliflozin and its carbon-13 labeled analogue[J].Tetrahedron Lett, 2016, 57(42): 4684-4687.
[17]
GOODWIN N C, HARRISON B A, KIMBALL S D, et al.Inhibitor of sodium glucose co-transpoter 2 and methods of their use: US, 20080221164A1 [P].2008-09-11.
[18]
DUFFY K J, FITCH D M, JIN J, et al.Polyl hydroxylase inhibitors: WO, 2007150011A2 [P].2007-12-27.
[19]
MURUGESAN N, GU Z X, FADNIS L, et al.Dual angiotensin II and endothelin a receptor antagonists: synthesis of 2′-substituted N-3-isoxazolyl biphenylsulfonamides with improved potency and pharmacokinetics [J].J Med Chem, 2005, 48(1): 171-179.
[20]
ERIC A, ANDREA D, LIU X F.2,2-Difluoropropionamide derivatives of bardoxolone methyl, polymorphic forms and methods of use thereof: WO, 2013163344A1 [P].2013-10-31.
[21]
HUANG J, ZHU L J, JIANG W, et al.Echinocandin analogues and preparation method therefor: WO, 2021110125 A1 [P].2021-06-10.
[22]
GRAHAM C N, PAULO F G D S P, NADEGE G, et al.Tetrahydro-pyrido-pyrimidine derivatives: WO, 2012004299A1 [P].2012-01-12.
[23]
HAMID H, GUILLAUME D, GRAEME F.Novel N-acyl-(3-substituted)-(8-substituted)-5,6-dihydro-[1,2,4]-triazolo[4,3-a]pyrazines as selective NK-3 receptor antagonists, pharmaceutical composition, methods for use in NK-3 receptor-mediated disorders: WO, 2014154895A1[P].2014-10-02.
[24]
IVANOV B P, LÖSCHER F, NICOLETTI S.Process for the preparation of semiflurorinated alkanes using grignard reagents: US, 20200339492A1 [P].2020-10-29.
[25]
RHYS O D, YOUNGJIN P M, RICHARDR M, et al.Nitrile-containing antiviral compounds: WO, 2021250648A1[P].2021-12-16.
[26]
FRANK B M, CASIMIRO-GARCIA A, CHE Y, et al.Pyrrolo[2,3-d]pyrimidinyl, pyrrolo[2,3-b]pyrazinyl and pyrrolo[2,3-d]pyridinyl acrylamides: WO, 2015083028A1[P].2015-06-11.
[27]
MARIE D J, GUANMIN W, JINGDAN H, et al.Process for making an isoxazoline compound and intermediate thereof: WO, 2022020585A1 [P].2022-01-27.
[28]
JEAN-MARC L, MARK R D, BRIAN S E.Retinoids for the treatment of emphysema: WO, 0228810A2 [P].2002-04-11.
[29]
JOHN B C, CRAIG D A, THOMAS F J, et al.Phenyl amino pyrimidine compounds and uses thereof: WO, 2008109943A1 [P].2008-09-18.
[30]
ROBERT M J, JUERG L, SANGDON H, et al.Substituted 1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl) acetic acid derivatives useful in the treatment of autoimmune and inflammatory disorders: WO, 2010011316A1 [P].2010-01-28.
[31]
EUGENE P O, RICHARD C R.Diuretic 1,4,9(11)-pregnatrienes: US, 3284477 [P].1966-11-08.
[32]
NOVARTIS A G, CHRISTOPHER A, MICHAEL P C, et al.Piperidinyl indole derivatives and their use as complement factor B inhibitors: WO, 2015009616A1 [P].2015-01-22.
2024年第55卷第1期
29
8
0
引用本文
BibTeX
文章信息
doi: 10.16522/j.cnki.cjph.2024.01.001
  • 接收时间:2024-01-01
  • 首发时间:2026-11-19
  • 出版时间:2024-01-10
补充材料
相关文章
文章信息
作者
出版历史
  • 收稿日期:2024-01-01
基金
作者信息
    中国医药工业研究总院上海医药工业研究院,上海 201203

通讯作者:

周伟澄(1958—),男,研究员,博士生导师,从事药物化学研究。E-mail:
参考文献
分享链接
https://castjournals.cast.org.cn/joweb/zgyygy/CN/10.16522/j.cnki.cjph.2024.01.001
分享至
全文二维码

扫描看全文

引用本文
BibTeX
本文的引用情况
2种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏